Musical Neurodynamics
Exploring the neural mechanisms of music-based therapy in Alzheimer's patients
April 2025
Music Medicine for Better Brain Health
Revolutionary digital therapeutics that combine the power of muscle with the latest breakthroughs in neuroscience
Research
Pioneering neuroscience breakthroughs to restore healthy brain function
Neural Oscillation Therapy
Our research focuses on understanding how disrupted brain rhythms in Alzheimer's patients can be restored through targeted stimulation.
- • Gamma wave entrainment reduces amyloid plaques
- • Music-based interventions enhance neuroplasticity
- • Non-invasive optical stimulation techniques
Clinical Trials
Phase 3 trials underway with 500+ participants across 12 sites
FDA Breakthrough
Designated as Breakthrough Device for Alzheimer's treatment
Neuroimaging
Real-time brain activity monitoring during treatment sessions
Technology
Cloud-native platform delivering precision neurotechnology therapy
Cloud-Native Neurotechnology
Our platform orchestrates personalized therapy through real-time brain monitoring and AI-driven optimization.
Music-Based Stimulation
Patient-selected music drives neural entrainment with dopamine release
Synchronized Light Pulses
40Hz gamma frequency stimulation for amyloid reduction
Real-Time Monitoring
Continuous EEG analysis for therapy optimization
AI Optimization
Machine learning models personalize treatment protocols
Cloud Integration
HIPAA-compliant data flow to caregivers and clinicians
Publications
Peer-reviewed research advancing neurotechnology
Gamma Entrainment Study
Clinical outcomes of 40Hz stimulation in mild cognitive impairment
March 2025
Music Therapy & Neuroplasticity
How personalized music enhances synaptic connectivity in aging brains
February 2025
Digital Biomarkers
Real-time cognitive assessment through digital therapeutic platforms
January 2025
Memory Enhancement Protocol
Systematic approach to reversing memory decline through neural stimulation
December 2024
Clinical Validation Study
Multi-site randomized controlled trial results in Alzheimer's patients
November 2024
Team
Leading neuroscientists and technologists transforming brain health
Dr. Sarah Chen
Chief Science Officer
PhD Neuroscience, MIT. 15+ years brain stimulation research
Marcus Rodriguez
CTO
Former Google Health. AI/ML for digital therapeutics
Dr. James Park
Clinical Director
MD Neurology. Led 200+ Alzheimer's trials
Lisa Wang
Head of Research
PhD Biomedical Engineering. Neural signal processing expert
David Kim
VP Product
Ex-Apple Health. 10+ years medical device experience
Dr. Amanda Foster
Regulatory Affairs
Former FDA reviewer. Neurology device approvals
Partners
Collaborating with leading institutions to advance neurotechnology
Strategic Collaborations
We partner with world-class research institutions, healthcare systems, and technology companies to accelerate breakthrough neurotechnology.
Academic Research Centers
Healthcare Systems
Technology Partners
MIT
Neural Engineering
Stanford
Alzheimer's Research
Cleveland Clinic
Clinical Trials
Google Health
AI Partnership
Become a Partner
Join our network of innovators advancing neurotechnology for brain health
Contact
Let's advance neurotechnology together
Research Inquiries
collaborate@oscillobiosciences.com
Media Relations
media@oscillobiosciences.com
Business Development
partnerships@oscillobiosciences.com
Careers
careers@oscillobiosciences.com
Contact
Let's advance neurotechnology together
Get in Touch
Research Inquiries
Get in Touch
Collaborate with Us
We partner with leading institutions to advance neurotechnology for brain health.